NCT01397370View on ClinicalTrials.gov

Multiple Ascending Dose Study of GLPG0492 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Healthy

Interventions

DRUG

GLPG0492

Oral solution

DRUG

Placebo

Oral solution

Trial Locations (1)

14050

Parexel Early Phase Clinical Unit, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galapagos NV

INDUSTRY